SERINC2-ZCCHC17 Fusion FISH Probe
The SERINC2-ZCCHC17 Fusion FISH Probe is used to confirm a fusion of the SERINC2 and ZCCHC17 genes. The fusion of the SERINC2 and ZCCHC17 genes has been associated with Lung Squamous Cell Carcinoma, Bladder Urothelial Carcinoma, and Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SERINC2-ZCCHC17-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-ZCCHC17-20-AQAQ | 20 (40 μL) | 200 μL |
|
ZCCHC17 Gene Summary
The Zinc Finger CCHC-type Containing 17 (ZCCHC17) gene is located on chr1 :31769841-31837780 at 1p35.2.
Gene Name: Zinc Finger CCHC-type Containing 17
Chromosome: CHR1: 31769841 -31837780
Locus: 1p35.2
SERINC2 Gene Summary
The Serine Incorporator 2 (SERINC2) gene is located on chr1 :31882411-31907527 at 1p35.2.
Gene Name: Serine Incorporator 2
Chromosome: CHR1: 31882411 -31907527
Locus: 1p35.2
Gene Diseases
The SERINC2 ZCCHC17 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
| Bladder Urothelial Carcinoma |
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|